You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Long-term follow-up of certolizumab pegol in uveitis due to immune-mediated inflammatory diseases: multicentre study of 80 patients

Article metrics

Article menu

Download PDFPDF

Miscellaneous
Original research
Long-term follow-up of certolizumab pegol in uveitis due to immune-mediated inflammatory diseases: multicentre study of 80 patients

 

Online download statistics by month:

Online download statistics by month: December 2022 to August 2024

AbstractFullPdf
Dec 202223122561
Jan 202324424397
Feb 202311511448
Mar 2023656045
Apr 2023696440
May 2023525235
Jun 2023565634
Jul 2023424119
Aug 2023504717
Sep 2023585522
Oct 2023555314
Nov 2023787725
Dec 2023737321
Jan 2024394024
Feb 2024686637
Mar 202410110054
Apr 202411311358
May 2024999739
Jun 2024888019
Jul 202416114423
Aug 2024706917
Total19271869749